Zepbound, Semaglutide, and Wegovy offer substantial benefits for effective long-term weight management
The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
The 8mg Dose At 8mg, weight loss jumps to 21.1% over 48 weeks
When the body becomes resistant to insulin, it may: store more fat struggle to regulate blood sugar increase cravings make weight loss more difficult Tirzepatide helps improve insulin sensitivity, allowing the body to use glucose more efficiently instead of storing excess energy as fat
Treatment goals : GLP-1s like semaglutide and tirzepatide have a growing list of approved and potential uses
At this stage, it would not be appropriate to make treatment decisions based on one study